Last reviewed · How we verify
Nitrous Oxide NO
At a glance
| Generic name | Nitrous Oxide NO |
|---|---|
| Also known as | N2O |
| Sponsor | Universidade Federal Fluminense |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Use of Nitrous Oxide for Pain and Anxiety Management During Cervical Cerclage Removal- A Multicenter Randomized Controlled Study (NA)
- Environmental Visual Distraction With Nitrous Oxide During Outpatient Hysteroscopy: A Randomized Pilot Study (NA)
- Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE) (NA)
- Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients (PHASE4)
- Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test (NA)
- The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial (PHASE4)
- Nitrous Oxide Neuroimaging (EARLY_PHASE1)
- Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Pain Following Thoracic Trauma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nitrous Oxide NO CI brief — competitive landscape report
- Nitrous Oxide NO updates RSS · CI watch RSS
- Universidade Federal Fluminense portfolio CI